Toll-like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Sep 7

PMID 22952664

Citations 18

Authors

Robert M Valente

Erica Ehlers

Dongsheng Xu

Humera Ahmad

Andrew Steadman

Laura Blasnitz

You Zhou

Lisa Kastanek

Bin Meng

Luwen Zhang

Affiliations

Soon will be listed here.

Abstract

Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus. Toll-like receptor 7 (TLR7) is involved in host innate immunity against pathogens, and its aberrant activation is linked to the development of systemic lupus erythematosus (SLE, also called "lupus"). Type I interferons (IFN) are apparently driving forces for lupus pathogenesis. Previously, we found that EBV latent membrane protein 1 (LMP1) primes cells for IFN production. In this report, the relationship among EBV LMP1, TLRs, and IFN production are examined. We find that TLR7 activation increases the expression of EBV LMP1, and IFN regulatory factor 7 (IRF7) is involved in the stimulation process. TLR7 activation did not induce IFNs from EBV-infected cells, but potentiates those cells for IFN production by TLR3 or TLR9 activation. In addition, we find that LMP1 and IFNs are co-expressed in the same cells in some lupus patients. Therefore, the aberrant activation of TLR7 might induce LMP1 expression and LMP1-expression cells may be producing IFNs in lupus patients. These results suggest EBV might be an exacerbating factor in some lupus patients via promoting IFN production.

Citing Articles

Immunomodulatory Role of Interferons in Viral and Bacterial Infections.

Mertowska P, Smolak K, Mertowski S, Grywalska E Int J Mol Sci. 2023; 24(12).

PMID: 37373262 PMC: 10298684. DOI: 10.3390/ijms241210115.

The Role of RNA Sensors in Regulating Innate Immunity to Gammaherpesviral Infections.

Zhang H, Sandhu P, Damania B Cells. 2023; 12(12).

PMID: 37371120 PMC: 10297173. DOI: 10.3390/cells12121650.

Comprehensive insight into altered host cell-signaling cascades upon Helicobacter pylori and Epstein-Barr virus infections in cancer.

Kashyap D, Rele S, Bagde P, Saini V, Chatterjee D, Jain A Arch Microbiol. 2023; 205(7):262.

PMID: 37310490 DOI: 10.1007/s00203-023-03598-6.

Potential role of EBV and Toll-like receptor 9 ligand in patients with systemic lupus erythematosus.

Izadi S, Najfizadeh S, Nejati A, TeimooriRad M, Shahmahmoodi S, Shirazi F Immunol Res. 2023; 71(5):698-708.

PMID: 37097524 DOI: 10.1007/s12026-023-09380-6.

Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting.

Stergioti E, Manolakou T, Boumpas D, Banos A Biomedicines. 2022; 10(11).

PMID: 36359340 PMC: 9687478. DOI: 10.3390/biomedicines10112820.

References

Ronnblom L, Alm G . An etiopathogenic role for the type I IFN system in SLE. Trends Immunol. 2001; 22(8):427-31. DOI: 10.1016/s1471-4906(01)01955-x. View

Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W . The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 2000; 19(12):3080-9. PMC: 203345. DOI: 10.1093/emboj/19.12.3080. View

Davidson D, Schauer S, Duong J, Kieff E . NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci U S A. 2000; 97(11):6055-60. PMC: 18557. DOI: 10.1073/pnas.100119497. View

Zhang L, Pagano J . Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency. Mol Cell Biol. 1999; 19(4):3216-23. PMC: 84115. DOI: 10.1128/MCB.19.4.3216. View

Incaprera M, Rindi L, Bazzichi A, Garzelli C . Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin Exp Rheumatol. 1998; 16(3):289-94. View

Niewold T, Kelly J, Flesch M, Espinoza L, Harley J, Crow M . Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum. 2008; 58(8):2481-7. PMC: 2621107. DOI: 10.1002/art.23613. View

Banchereau J, Pascual V, Palucka A . Autoimmunity through cytokine-induced dendritic cell activation. Immunity. 2004; 20(5):539-50. DOI: 10.1016/s1074-7613(04)00108-6. View

Frost V, Delikat S, Sinclair A . Regulation of p27KIP1 in Epstein-Barr virus-immortalized lymphoblastoid cell lines involves non-apoptotic caspase cleavage. J Gen Virol. 2001; 82(Pt 12):3057-3066. DOI: 10.1099/0022-1317-82-12-3057. View

Mitarnun W, Pradutkanchana J, Takao S, Saechan V, Suwiwat S, Ishida T . Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis. J Med Assoc Thai. 2002; 85(5):552-9. View

10.

Stowell N, Seideman J, Raymond H, Smalley K, Lamb R, Egenolf D . Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respir Res. 2009; 10:43. PMC: 2694181. DOI: 10.1186/1465-9921-10-43. View

11.

Kang I, Quan T, Nolasco H, Park S, Hong M, Crouch J . Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol. 2004; 172(2):1287-94. DOI: 10.4049/jimmunol.172.2.1287. View

12.

Kanda K, Decker T, Aman P, Wahlstrom M, von Gabain A, Kallin B . The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3. Mol Cell Biol. 1992; 12(11):4930-6. PMC: 360425. DOI: 10.1128/mcb.12.11.4930-4936.1992. View

13.

Aman P, von Gabain A . An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced anti-proliferative response in human B-lymphoid cell lines. EMBO J. 1990; 9(1):147-52. PMC: 551640. DOI: 10.1002/j.1460-2075.1990.tb08090.x. View

14.

Ronnblom L, Alm G, Oberg K . Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. Acta Oncol. 1991; 30(4):537-40. DOI: 10.3109/02841869109092414. View

15.

Subramanian S, Tus K, Li Q, Wang A, Tian X, Zhou J . A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A. 2006; 103(26):9970-5. PMC: 1502563. DOI: 10.1073/pnas.0603912103. View

16.

Lepelley A, Louis S, Sourisseau M, Law H, Pothlichet J, Schilte C . Innate sensing of HIV-infected cells. PLoS Pathog. 2011; 7(2):e1001284. PMC: 3040675. DOI: 10.1371/journal.ppat.1001284. View

17.

Zhang L, Pagano J . Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. J Virol. 2000; 74(3):1061-8. PMC: 111439. DOI: 10.1128/jvi.74.3.1061-1068.2000. View

18.

Cahir McFarland E, Izumi K, Mosialos G . Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene. 1999; 18(49):6959-64. DOI: 10.1038/sj.onc.1203217. View

19.

Salloum R, Franek B, Kariuki S, Rhee L, Mikolaitis R, Jolly M . Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 2010; 62(2):553-61. PMC: 2832192. DOI: 10.1002/art.27182. View

20.

Samuel C . Antiviral actions of interferons. Clin Microbiol Rev. 2001; 14(4):778-809, table of contents. PMC: 89003. DOI: 10.1128/CMR.14.4.778-809.2001. View